Waters Corp

Waters Corp (WAT) Stock Analysis

$436.950

-7.079 (-1.62%)At close

Loading chart…
High
447.960
Open
444.480
VWAP
439.04
Volume
901.95K
Mkt Cap
16.99B
Low
432.200
Amount
395.99M
EV/EBITDA, TTM
37.60

Waters Corporation is a global life sciences and diagnostics company. The Company offers analytical instruments, separations technologies, and software, serving life, materials, food, and environmental sciences. Its segments include Waters and TA. The Company primarily designs, manufactures, sells and services high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. The Company designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments through its TA Instruments (TA) product line. The Company is also a developer and supplier of advanced software-based products that interface with the Company’s instruments, as well as other manufacturers’ instruments.

AI analysis of Waters Corp (WAT)

Buy

Waters Corp (WAT) is a good buy right now, as it is currently priced at $433.77, with a forward P/E ratio of 24.75, suggesting reasonable valuation compared to its growth potential. The stock has shown a strong year-to-date change of +13.56% and a one-year change of +28.97%, indicating solid performance. However, there is a risk with insider selling increasing by 125.80% over the last quarter, which could signal caution among insiders.

Analyst Ratings (15)

-5.23% Downside
Hold
5 Buy
9 Hold
1 Sell
Current: 436.95
Low
350.00
Average
414.08
High
480.00

BofA

2026-10-09

Price Target

$465

Neutral

Barclays

2026-10-07

Price Target

$500

Overweight

Guggenheim

2026-10-01

Price Target

$490

Buy

Goldman Sachs

2026-09-21

Price Target

$515

Buy

UBS

2026-09-09

Price Target

$490

Buy

Valuation Metrics

The current forward P/E ratio for Waters Corp (WAT) is 24.75, compared to its 5-year average forward P/E of 25.71.

Forward P/E

Fair
5Y Average P/E
25.71
Current P/E
24.75
Overvalued
29.03
Undervalued
22.39

Forward EV/EBITDA

Overvalued
5Y Average EV/EBITDA
21.87
Current EV/EBITDA
37.60
Overvalued
34.07
Undervalued
9.68

Forward P/S

Fair
5Y Average P/S
6.12
Current P/S
6.11
Overvalued
7.10
Undervalued
5.14

Alphio AI Price Scenarios for WAT

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%WAT

$494.79

Scenario price

B

Base

Base · 50%WAT

$430.97

Scenario price

B

Bear

Bear · 25%WAT

$340.64

Scenario price

Whales holding WAT

M

Mawer Investment Management Ltd.

+ HoldingWAT

+9.95%

3M Return

J

John W. Bristol & Co., Inc.

+ HoldingWAT

+8.30%

3M Return

A

Allspring Global Investments, LLC

+ HoldingWAT

+7.57%

3M Return

O

Osmosis Investment Management UK Limited

+ HoldingWAT

+7.21%

3M Return

F

Focus Partners Wealth, LLC

+ HoldingWAT

+6.22%

3M Return

M

Meridiem Capital Partners LP

+ HoldingWAT

+5.65%

3M Return

WAT FAQ — answered by Alphio AI

Waters Corporation is a global life sciences and diagnostics company. The Company offers analytical instruments, separations technologies, and software, serving life, materials, food, and environmental sciences. Its segments include Waters and TA. The Company primarily designs, manufactures, sells and services high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. The Company designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments through its TA Instruments (TA) product line. The Company is also a developer and supplier of advanced software-based products that interface with the Company’s instruments, as well as other manufacturers’ instruments. It operates in the Healthcare sector (LABORATORY ANALYTICAL INSTRUMENTS industry).

Waters Corp (WAT) is a good buy right now, as it is currently priced at $433.77, with a forward P/E ratio of 24.75, suggesting reasonable valuation compared to its growth potential. The stock has shown a strong year-to-date change of +13.56% and a one-year change of +28.97%, indicating solid performance. However, there is a risk with insider selling increasing by 125.80% over the last quarter, which could signal caution among insiders.

15 analysts cover WAT: 5 rate it Buy, 9 Hold and 1 Sell. The average price target is 414.08.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading